The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2019PET Tracer to Support Trials of Drugs Inhibiting Neuroinflammation via the NLRP3 Inflammasome
Study Rationale:
Chronic inflammation of immune cells our brains is now believed to be associated with the onset and progression of Parkinson’s disease. These cells produce a target in Parkinson’s... -
Research Grant, 2018The Effect of Psychological Stress on the Symptoms of Parkinson's Disease
Study Rationale:
Many people with Parkinson's disease (PD) experience chronic stress and associated disorders, such as depression, anxiety or both. Furthermore, many people with PD notice worsening of... -
Alpha-Synuclein Biology and Therapies, 2019Studying the Impact of Alpha-synuclein on Fatty Substances to Identify New Parkinson's Disease Drug Targets
Study Rationale:
Alpha-synuclein is a sticky protein that clumps in the brains of people with Parkinson's disease (PD). It can attach itself and interact with fatty substances called lipids and fatty... -
Research Grant, 2018Studying Measures of LRRK2 Activation and Lysosomal Dysfunction in Parkinson's Disease
Study Rationale:
As new, targeted therapies for Parkinson's disease (PD) enter clinical trials, biomarkers -- objective measures of disease --become increasingly important as tools for matching people... -
Research Grant, 2019Diagnosing Early-Stage Parkinson’s Disease via a Urine Test for Extracellular Vesicles
Objective/Rationale:
There is a great need to develop new, readily accessible biomarkers — objective measures of disease — from biofluids (blood, urine, saliva or cerebrospinal fluid) for early... -
Research Grant, 2018Developing New Drugs that Deactivate Deubiquitinase Proteins for the Treatment of Parkinson's Disease
Promising Outcomes of Original Grant:
In our past studies, we aimed to identify small molecule inhibitors of proteins called deubiquitinases (DUBs), i.e., chemicals that makes DUBs unable to perform...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.